ATE466958T1 - Klassifizierung von kolonkrebs - Google Patents
Klassifizierung von kolonkrebsInfo
- Publication number
- ATE466958T1 ATE466958T1 AT04803064T AT04803064T ATE466958T1 AT E466958 T1 ATE466958 T1 AT E466958T1 AT 04803064 T AT04803064 T AT 04803064T AT 04803064 T AT04803064 T AT 04803064T AT E466958 T1 ATE466958 T1 AT E466958T1
- Authority
- AT
- Austria
- Prior art keywords
- cancer
- classification
- colon cancer
- treatment
- relates
- Prior art date
Links
- 206010009944 Colon cancer Diseases 0.000 title 1
- 208000029742 colonic neoplasm Diseases 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 5
- 201000011510 cancer Diseases 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 3
- 108091092878 Microsatellite Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000014509 gene expression Effects 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301940 | 2003-12-27 | ||
| DKPA200400096 | 2004-01-24 | ||
| DKPA200400586 | 2004-04-07 | ||
| DKPA200401843 | 2004-11-26 | ||
| PCT/DK2004/000914 WO2005064009A1 (en) | 2003-12-27 | 2004-12-23 | Classification of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE466958T1 true ATE466958T1 (de) | 2010-05-15 |
Family
ID=34743750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04803064T ATE466958T1 (de) | 2003-12-27 | 2004-12-23 | Klassifizierung von kolonkrebs |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090297506A1 (de) |
| EP (1) | EP1704248B1 (de) |
| AT (1) | ATE466958T1 (de) |
| CA (1) | CA2592504A1 (de) |
| DE (1) | DE602004027086D1 (de) |
| WO (1) | WO2005064009A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1672079A1 (de) * | 2004-12-20 | 2006-06-21 | Georg-August-Universität Göttingen Stiftung öffentlichen Rechts | Verfahren für Krebsdiagnose |
| NZ544432A (en) * | 2005-12-23 | 2009-07-31 | Pacific Edge Biotechnology Ltd | Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS |
| WO2008141480A1 (en) * | 2007-05-22 | 2008-11-27 | Human Antibodomics (Shanghai) Inc. | Human angiostatin interacting and tumor metastasis involving protein variants and uses thereof |
| EP2218794A1 (de) * | 2009-02-13 | 2010-08-18 | Alphagenics International SA | Instabilitätserkennung in Regionen mit genomischem DNA mit einfacher Tandemwiederholung |
| US10036070B2 (en) * | 2010-12-23 | 2018-07-31 | Agendia N.V. | Methods and means for molecular classification of colorectal cancers |
| US20150301068A1 (en) | 2012-01-30 | 2015-10-22 | Vib Vzw | Means and method for diagnosis and treatment of alzheimer's disease |
| EP2700949A1 (de) | 2012-08-24 | 2014-02-26 | IMG Institut für medizinische Genomforschung Planungsgesellschaft M.B.H. | Verwendung von Biliverdinreduktaseproteinen als Krebsmarker |
| EP4098278A1 (de) * | 2014-11-13 | 2022-12-07 | The Johns Hopkins University | Checkpoint-blockade und mikrosatelliteninstabilität |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1361286A1 (de) * | 2002-04-18 | 2003-11-12 | MTM Laboratories AG | Methode, um Krebs zu detektieren |
-
2004
- 2004-12-23 US US10/584,653 patent/US20090297506A1/en not_active Abandoned
- 2004-12-23 DE DE602004027086T patent/DE602004027086D1/de not_active Expired - Lifetime
- 2004-12-23 EP EP04803064A patent/EP1704248B1/de not_active Expired - Lifetime
- 2004-12-23 CA CA002592504A patent/CA2592504A1/en not_active Abandoned
- 2004-12-23 WO PCT/DK2004/000914 patent/WO2005064009A1/en not_active Ceased
- 2004-12-23 AT AT04803064T patent/ATE466958T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1704248B1 (de) | 2010-05-05 |
| CA2592504A1 (en) | 2005-07-14 |
| WO2005064009A9 (en) | 2009-11-05 |
| DE602004027086D1 (de) | 2010-06-17 |
| US20090297506A1 (en) | 2009-12-03 |
| WO2005064009A1 (en) | 2005-07-14 |
| EP1704248A1 (de) | 2006-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004027600D1 (de) | Genexpressionsmarker für die prognose von brustkrebs | |
| BRPI0411743A (pt) | método e composições para tratar doenças relacionadas a amilóides | |
| BR0315689A (pt) | Alvo para terapia de dano cognitivo | |
| TW200600087A (en) | Methods and compositions for treating amyloid-related diseases | |
| HUP0402239A2 (hu) | Eltérően oxialkilezett poliolok keverékén alapuló, sugárzásra keményedő uretán-akrilátok | |
| ATE443260T1 (de) | Kontrastmittel und verfahren zum imaging von naaldase oder psma | |
| DK1781697T3 (da) | Nyt carbamyleret erythropoietinprotein samt fremstillingsmetode | |
| EP1990059A3 (de) | Verfahren zur Behandlung von Krebs | |
| BRPI0606287A2 (pt) | processo para a produção de silicones monofuncionais monodispersos e dispersos limitados | |
| MY142988A (en) | Novel aminobenzophenone compounds | |
| DE60314500D1 (de) | Diaminopyrimidine und deren verwendung als angiogenesehemmer | |
| ATE492651T1 (de) | Moesin, caveolin 1 und yes-assoziiertes protein 1 als prädiktive marker der reaktion auf dasatinib bei brustkrebs | |
| DE60332096D1 (de) | Mikrosatellitenmarker in form von mononukleotidwiederholungen zur detektion von mikrosatelliteninstabilität | |
| DE602004016499D1 (de) | Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung | |
| NO20055741L (no) | Nye kjemiske forbindelser | |
| DE60109430D1 (de) | An entzündlichen darmerkrankungen beteiligte gene und deren verwendung | |
| DE602004031458D1 (de) | Verfahren zur erhöhung der refinerproduktionsrate und/oder verringerung der spezifischen energie des aufschliessens von holz | |
| DE602004027086D1 (de) | Klassifizierung von kolonkrebs | |
| DE10345021A1 (de) | Verfahren zur nichtinvasiven Früherkennung von Dickdarmkrebs und/oder Darmkrebsvorläuferzellen | |
| DE602004023199D1 (de) | Fluoreszenzprotein und pigmentprotein | |
| ECSP056057A (es) | Compuestos de benzo[1,2,5]tiadiazole | |
| BRPI0415355A (pt) | triarilimidazóis | |
| BRPI0408238A (pt) | anticorpo, método de detectar cáncer, conjunto para detecção de cáncer, e, composição farmacêutica para tratar cáncer | |
| ATE447610T1 (de) | Kristalliner vap-1 und verwendung | |
| WO2003030719A3 (en) | Methods and kits for use in selecting approaches to treating cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |